Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism

Journal of Experimental Medicine

Volumn 186, Issue 4, 1997, Pages 549-560

  Villadangos, José A ^a   Riese, Richard J ^b   Peters, Christoph ^c   Chapman, Harold A ^b   Ploegh, Hidde L ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME DEGRADATION; GENETIC POLYMORPHISM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CATHEPSIN D; CATHEPSINS; CRICETINAE; CYSTEINE PROTEINASE INHIBITORS; HISTOCOMPATIBILITY ANTIGENS CLASS II; LEUPEPTINS; MICE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RABBITS;

EID: 0030790341     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.4.549     Document Type: Article

References (78)

1. Wolf, P.R., and H.L. Ploegh. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Anim. Rev. Cell Dev. Biol. 11:267-306.
2. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:707-716.
3. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S.L. Schmid, V. Quaranta, and P.A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature (Lond.). 348:600-605.
4. Chicz, R.M., R.G. Urban, J.C. Gorga, D.A.A. Vignali, W.S. Lane, and J.L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27-47.
5. Gosh, P., M. Amaya, E. Mellins, and D.C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature (Lond.). 378:457-462.
6. Bijlmakers, M.J., P. Benaroch, and H. Ploegh. 1994. Mapping functional regions in the lumenal domain of the class II associated invariant chain. J. Exp. Med. 180:623-629.
7. Romagnoli, P., and R.N. Germain. 1994. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 180:1107-1113.
8. Busch, R., I. Cloutier, R.P. Sekaly, and G.J. Hammerling. 1996. Invariant chain protects class II histocompatibility antigens from binding intact proteins in the endoplasmic reticulum. EMBO (Eur. Mol. Biol. Organ.) J. 15:418-428.
9. Sadegh-Nasseri, S., L.J. Stern, D.C. Wiley, and R.N. Germain. 1994. MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature (Lond.). 370:647-650.
10. Zhong, G., F. Castellino, P. Romagnoli, and R.N. Germain. 1996. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 184:2061-2066.
11. Mellins, E., L. Smith, B. Arp, T. Cotner, E. Celis, and D. Pious. 1990. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature (Lond.). 343:71-74.
12. Riberdy, J.M., and P. Cresswell. 1992. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J. Immunol. 148:2586-2590.
13. Ceman, S., R. Rudershof, E.O. Long, and R. Demars. 1992. MHC class II deletion mutant expresses normal levels of transgene encoded class II molecules that have abnormal conformation and impaired antigen presentation ability. J. Immunol. 149:754-761.
14. Sette, A., S. Ceman, R.T. Kubo, K. Sakaguchi, E. Apella, D.F. Hunt, T.A. Davis, H. Michel, J. Shabanowitz, R. Rudersdorf, H.M. Grey, and R. DeMars. 1992. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science (Wash. DC). 258:1801-1804.
15. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H.L. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H-2M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531-541.
16. Martin, W.D., G.G. Hicks, S.K. Mendiratta, H.I. Leva, H.E. Ruley, and L. Van Kaer. 1996. H-2M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell. 84:543-550.
17. Fung-Leung, W.P., C.D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P.A. Peterson, S.R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H-2M-deficient mice. Science (Wash. DC). 271:1278-1281.
18. Cresswell, P. 1994. Getting peptides into MHC class II molecules. Curr. Biol. 4:541-543.
19. Sloan, V.S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D.M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature (Lond.). 375:802-806.
20. Denzin, L.K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αη dimers and facilitates peptide loading. Cell. 82:155-165.
21. Sherman, M.A., D.A. Weber, and P.E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity. 3:197-205.
22. Sanderson, F.C., C. Thomas, J.J. Neefjes, and J. Trowsdale. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity. 4:87-96.
23. Denzin, L.K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184:2153-2165.
24. Kropshofer, H., S.O. Arndt, G. Moldenhauer, G.J. Hammerling, and A.B. Vogt. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity. 6:293-302.
25. Roche, P.A., and P. Cresswell. 1991. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA. 88:3150-3154.
26. Reyes, V.E., S. Lu, and R.E. Humphreys. 1991. Cathepsin B cleavage of Ii from class II MHC α- and β-chains. J. Immunol. 146:3877-3880.
27. Avva, R.R., and P. Cresswell. 1994. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity. 9:763-774.
28. Diment, S. 1990. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. J. Immunol. 145: 417-422.
29. Rodriguez, G.M., and S. Diment. 1992. Role of cathepsin D in antigen presentation of ovalbumin. J. Immunol. 149:2894-2898.
30. van Noort, J.M., and M.J.M. Jacobs. 1994. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II molecules. Eur. J. Immunol. 24:2175-2180.
31. Daibata, M., M. Xu, R.E. Humphreys, and V.E. Reyes. 1994. More efficient peptide binding to MHC class II molecules during cathepsin B digestion of Ii than after Ii release. Mol. Immun. 31:255-260.
32. Blum, J.S., and P. Cresswell. 1988. Role of intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA. 85:3975-3979.
33. Neefjes, J.J., and H.L. Ploegh. 1992. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers. EMBO (Eur. Mol. Biol. Organ.) J. 11:411-416.
34. Maric, M.A., M.D. Taylor, and J.S. Blum. 1994. Endosomal aspartic proteinases are required for invariant-chain processing. Proc. Natl. Acad. Sci. USA. 91:2171-2175.
35. Morton, P.A., M.L. Zacheis, K.S. Giacoletto, J.A. Manning, and B.D. Schwartz. 1995. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J. Immunol. 154: 137-150.
36. Vidard, L., K. Rock, and B. Benacerraf. 1991. The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors. J. Immunol. 147: 1786-1791.
37. Riese, R.J., P.R. Wolf, D. Brömme, L.R. Natkin, J.A. Villadangos, H.L. Ploegh, and H.A. Chapman. 1996. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity. 4:357-366.
38. Shi, G.P., A.C. Webb, K.E. Foster, J.H.M. Knoll, C.A. Lemere, J.S. Munger, and H.A. Chapman. 1994. Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J. Biol. Chem. 269:11530-11536.
39. Amigorena, S., P. Webster, J. Drake, J. Newcomb, P. Cresswell, and I. Mellman. 1995. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. Exp. Med. 181:1729-1741.
40. Brachet, V., G. Raposo, S. Amigorena, and I. Mellman. 1997. Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J. Cell Biol. 137:51-65.
41. Brömme, D., and M.E. McGrath. 1996. High levels of expression of human cathepsin S and its crystallization. Protein Sci. 5:789-791.
42. Metlay, J.P., M.D. Witmer-Pack, R. Agger, M. Crowley, D. Lawless, and R.M. Steinman. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171:1753-1771.
43. Mehringer, J., M. Harris, C. Kindle, D. McCourt, and S. Cullen. 1991. Characterization of fragments of the murine Ii-associated invariant chain. J. Immunol. 146:920-927.
44. Sant, A.J., L.R. Hendrix, J.E. Coligan, W.L. Maloy, and R.N. Germain. 1991. Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex α/β chains. J. Exp. Med. 174:799-808.
45. Saftig, P., M. Hetman, W. Schmahl, K. Weber, L. Heine, H. Mossman, A. Köster, B. Hess, M. Evers, K. von Figura, and C. Peters. 1995. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO (Eur. Mol. Biol. Organ.) J. 14:3599-3608.
46. Laird, P.W., A. Zijderveld, K. Linders, M.A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
47. Cresswell, P. 1994. Assembly, transport and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293.
48. Germain, R.N., and L.R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature (Lond.). 353: 134-139.
49. Seglen, P.O. 1983. Inhibitors of lysosomal function. Meth. Enzymol. 96:737-765.
50. Romagnoli, P., C. Layet, J. Yewdell, O. Bakke, and R.N. Germain. 1993. Relationship between invariant chain expression and MHC class II transport into early and late endocytic compartments. J. Exp. Med. 177:583-596.
51. Peters, P.J., G. Raposo, J.J. Neefjes, V. Oorschot, R.L. Leijendekker, H.J. Geuze, and H.L. Ploegh. 1995. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J. Exp. Med. 182:325-334.
52. Palmer, J.T., D. Rasnick, J.L. Klaus, and D. Brömme. 1995. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J. Med. Chem. 38:3193-3196.
53. Mason, R.W., D. Wilcox, P. Wikstrom, and E.N. Shaw. 1989. The identification of active forms of active cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of specific radiolabeled inhibitor. Biochem. J. 257:125-129.
54. Kasai, M., K. Hirokawa, K. Kajino, K. Ogasawara, M. Tatsumi, E. Hermel, J.J. Monaco, and T. Mizuochi. 1996. Difference in antigen presentation pathways between cortical and medullary thymic epithelial cells. Eur. J. Immunol. 26: 2101-2107.
55. Bikoff, E.K., R.N. Germain, and E.J. Robertson. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity. 2:301-310.
56. Stebbins, C.C., G.E. Loss, C.G. Elias, A. Chervonsky, and A.J. Sant. 1995. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J. Exp. Med. 181:223-234.
57. Ploegh, H.L., and U. Fuhrmann. 1985. Manipulation of glycans on antigens of the major histocompatibility complex. In Cell Biology of the Major Histocompatibility Complex. B. Permis and H. Vogel, editors. Academic Press, New York. 133-151.
58. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:287-299.
59. Xu, M., G.A. Capraro, M. Daibata, V.E. Reyes, and R.E. Humphreys. 1994. Cathepsin B cleavage and release of invariant chain from MHC class II molecules follow a staged pattern. Mol. Immun. 31:723-731.
60. Riberdy, J.M., J.R. Newcomb, M.J. Surman, J.A. Barbosa, and P. Cresswell. 1992. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature (Lond.). 360:474-476.
61. Amigorena, A., J. Drake, P. Webster, and I. Mellman. 1994. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature (Lond.). 369:113-120.
62. Tulp, A., D. Verwoerd, B. Dobberstein, H.L. Ploegh, and J. Pieters. 1994. Isolation and characterization of the intracellular MHC class II compartment. Nature (Lond.). 369:120-126.
63. West, M., J. Lucocq, and C. Watts. 1994. Antigen processing and Class II MHC peptide loading compartments in human B lymphoblastoid cells. Nature (Lond.). 369:147-150.
64. Qiu, Y., A. Wandinger-Ness, D.P. Dalke, and S.K. Pierce. 1994. Separation of subcellular compartments containing distinct functional forms of MHC class II. J. Cell Biol. 125: 595-605.
65. Rudensky, A.Y., M. Maric, S. Eastman, L. Shoemaker, P.C. DeRoos, and J.S. Blum. 1994. Intracellular assembly and transport of endogenous peptide-MHC class II complexes. Immunity. 1:585-594.
66. Castellino, F., and R.N. Germain. 1995. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity. 2:73-88.
67. Newcomb, J.R., and P. Cresswell. 1993. Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo. J. Immunol. 151:4153-4163.
68. Myers, C. 1991. Role of B cell antigen processing and presentation in the humoral immune response. FASEB J. 5: 2547-2553.
69. Barois, N., F. Forquet, and J. Davoust. 1997. Selective modulation of the major histocompatibility complex class II antigen presentation pathway following B cell receptor ligation and protein kinase C activation. J. Biol. Chem. 272:3641-3647.
70. Peters, P.J., J.J. Neefjes, V. Oorschot, H.L. Ploegh, and H.J. Geuze. 1991. Segregation of MHC class II molecules from MHC class I molecules in the golgi complex for transport to lysosomal compartments. Nature (Lond.). 349:669-676.
71. Fernandez-Borja, M., D. Verwoerd, F. Sanderson, H. Aerts, J. Trowsdale, A. Tulp, and J. Neefjes. 1996. HLA-DM and MHC class II molecules co-distribute with peptidase-containing lysosomal subcompartments. Int. Immunol. 8:625-640.
72. Malcherek, G., V. Gnau, G. Jung, H.G. Rammensee, and A. Melms. 1995. Supermotifs enable natural invariant chain-derived peptides to interact with many major hystocompatibility complex-class II molecules. J. Exp. Med. 181:527-536.
73. Sette, A., S. Southwood, J. Miller, and E. Appella. 1995. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 181:677-683.
74. Adorini, L., J.C. Guery, S. Fuchs, V. Ortiz-Navarrete, G.J. Hammerling, and F. Momburg. 1993. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells. J. Immunol. 151:3576-3586.
75. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E.O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature (Lond.). 375:603-606.
76. Zhong, G., P. Romagnoli, and R.N. Germain. 1997. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J. Exp. Med. 185:429-438.
77. Puri, J., and Y. Factorovich. 1988. Selective inhibition of antigen presentation to cloned T cells by protease inhibitors. J. Immunol. 141:3313-3317.
78. Chicz, R.M., R.G. Urban, W.S. Lane, J.C. Gorga, L.J. Stern, D.A.A. Vignali, and J.L. Strominger. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogenous in size. Nature (Lond.). 358:764-768.